Currently Viewing:
Interviews
Interviews
Currently Reading
Dr Melinda Magyari Explores What Registries Reveal About Pediatric MS
December 16, 2019
December 09, 2019
December 02, 2019
November 25, 2019
November 18, 2019
November 11, 2019
October 28, 2019
October 14, 2019
Dr Melinda Magyari Explores What Registries Reveal About Pediatric MS
Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, explores what data registry have shown about factors that are linked with secondary progression in pediatric multiple sclerosis (MS).
Melinda Magyari, MD, PhD, Consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, explores what data registry have shown about factors that are linked with secondary progression in pediatric multiple sclerosis (MS).
Transcript
Have registry data revealed any factors related to secondary progression in pediatric MS?
The definition of secondary progression, it's very difficult. So you need to use a composite definition as a proxy. And that's a really hot topic, how to do that composite definition. Also because clinicians are reluctant to define the disease progression because there is no current treatment for secondary progressive MS. However, you see in 2 big, good registries that children progress slowly, but they reach secondary progression phase at a younger age, so 10 years younger than adults.
Transcript
Have registry data revealed any factors related to secondary progression in pediatric MS?
The definition of secondary progression, it's very difficult. So you need to use a composite definition as a proxy. And that's a really hot topic, how to do that composite definition. Also because clinicians are reluctant to define the disease progression because there is no current treatment for secondary progressive MS. However, you see in 2 big, good registries that children progress slowly, but they reach secondary progression phase at a younger age, so 10 years younger than adults.
